Angiodysplasia pathophysiology

Jump to navigation Jump to search

Angiodysplasia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Angiodysplasia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Angiodysplasia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Angiodysplasia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Angiodysplasia pathophysiology

CDC on Angiodysplasia pathophysiology

Angiodysplasia pathophysiology in the news

Blogs on Angiodysplasia pathophysiology

Directions to Hospitals Treating Angiodysplasia

Risk calculators and risk factors for Angiodysplasia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nikita Singh, M.B.B.S.[2]

Overview

The exact pathogenesis of angiodysplasia is unknown. It has been proposed that chronic obstruction of submucosal veins coupled with the effect of aging, ultimately lead to the formation of small arterio-venous collaterals. Angiogenic factors have also been found to play a role in the development of angiodysplasia.

Pathophysiology

  • The exact pathogenesis of angiodysplasia is still unknown.
  • According to a theory, angiodysplasia develops due to chronic obstruction of submucosal veins coupled with the effect of ageing, ultimately leading to the formation of small arterio-venous collaterals.[1]
  • Some studies have revealed increased levels of angiogenic factors like vascular endothelial growth factor (VEGF), angiopoietin-1 (Ang1), Ang2, etc., in small bowel and human colonic angiodysplasia.[2][3]
  • It has also been proposed that aortic stenosis, von Willebrand disease, and chronic renal failure by various mechanisms contribute to development of angiodysplasia.[1]

Associated Conditions

The following conditions have been reported to be associated with angiodysplasia:

Gross Pathology

  • Angiodysplasia is particularly difficult to recognise on gross examination of a resection specimen without the use of specific injection techniques.[8]
  • Angiodysplasia can be seen easily on endoscopy. The most common appearance on endoscopy is a flat, red lesion with a fern-like or regular margin.

Histology

References

  1. 1.0 1.1 Sami SS, Al-Araji SA, Ragunath K (2014). "Review article: gastrointestinal angiodysplasia - pathogenesis, diagnosis and management". Aliment Pharmacol Ther. 39 (1): 15–34. doi:10.1111/apt.12527. PMID 24138285.
  2. Holleran G, Hussey M, Smith S, McNamara D (2017). "Assessment of serum angiogenic factors as a diagnostic aid for small bowel angiodysplasia in patients with obscure gastrointestinal bleeding and anaemia". World J Gastrointest Pathophysiol. 8 (3): 127–132. doi:10.4291/wjgp.v8.i3.127. PMC 5561433. PMID 28868182.
  3. Holleran G, Hall B, O'Regan M, Smith S, McNamara D (2015). "Expression of Angiogenic Factors in Patients With Sporadic Small Bowel Angiodysplasia". J Clin Gastroenterol. 49 (10): 831–6. doi:10.1097/MCG.0000000000000260. PMID 25319741.
  4. 4.0 4.1 Warkentin TE, Moore JC, Anand SS, Lonn EM, Morgan DG (2003). "Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand syndrome". Transfus Med Rev. 17 (4): 272–86. doi:10.1016/s0887-7963(03)00037-3. PMID 14571395.
  5. Pate GE, Chandavimol M, Naiman SC, Webb JG (2004). "Heyde's syndrome: a review". J Heart Valve Dis. 13 (5): 701–12. PMID 15473466.
  6. Tariq T, Karabon P, Irfan FB, Goyal S, Mayeda MM, Parsons A; et al. (2019). "Secondary angiodysplasia-associated gastrointestinal bleeding in end-stage renal disease: Results from the nationwide inpatient sample". World J Gastrointest Endosc. 11 (10): 504–514. doi:10.4253/wjge.v11.i10.504. PMC 6885446 Check |pmc= value (help). PMID 31798771.
  7. Marie I, Ducrotte P, Antonietti M, Herve S, Levesque H (2008). "Watermelon stomach in systemic sclerosis: its incidence and management". Aliment Pharmacol Ther. 28 (4): 412–21. doi:10.1111/j.1365-2036.2008.03739.x. PMID 18498445.
  8. Koga H, Iida M, Nagai E, Aoyagi K, Matsumoto T, Takesue M; et al. (1996). "Jejunal angiodysplasia confirmed by intravascular injection technique in vitro. Report of a case and review of the literature". J Clin Gastroenterol. 23 (2): 139–44. doi:10.1097/00004836-199609000-00017. PMID 8877645.
  9. Thelmo WL, Vetrano JA, Wibowo A, DiMaio TM, Cruz-Vetrano WP, Kim DS (1992). "Angiodysplasia of colon revisited: pathologic demonstration without the use of intravascular injection technique". Hum Pathol. 23 (1): 37–40. doi:10.1016/0046-8177(92)90008-q. PMID 1544666.
  10. Accordino R, Paties C, Inzani E, Civardi C, Cremonesi V, Lagasi L; et al. (1995). "[Angiodysplasia of the right colon]". Minerva Chir. 50 (7–8): 703–6. PMID 8532207.

Template:WS Template:WH